---
input_text: 'Outcomes following kidney transplantation in patients with sickle cell
  disease: The impact of automated exchange blood transfusion. There are over 12,000
  people with sickle cell disease (SCD) in the UK, and 4-12% of patients who develop
  Sickle Cell Nephropathy (SCN) progress to End Stage Renal Disease (ESRD). Renal
  transplantation offers the best outcomes for these patients with but their access
  to transplantation is often limited. Regular automated exchange blood transfusions
  (EBT) reduce the complications of SCD and may improve outcomes. However, concerns
  over alloimmunisation limit its widespread implementation. In this retrospective
  multicenter study, data were collected on 34 SCD patients who received a kidney
  transplant across 6 London Hospitals between 1997 and 2017. 20/34 patients were
  on an EBT program, pre or post renal transplantation. Overall patient and graft
  survival were inferior to contemporaneous UK data in the ESRD population as a whole,
  a finding which is well-recognised. However, patient survival (CI 95%, p = 0.0032),
  graft survival and graft function were superior at all time-points in those who
  received EBT versus those who did not. 4/20 patients (20%) on EBT developed de novo
  donor specific antibodies (DSAs). 3/14 patients (21%) not on EBT developed de novo
  DSAs. The incidence of rejection in those on EBT was 5/18 (28%), as compared with
  7/13 (54%) not on EBT. In conclusion, our data, while limited by an inevitably small
  sample size and differences in the date of transplantation, do suggest that long-term
  automated EBT post renal transplant is effective and safe, with improvement in graft
  and patient outcomes and no increase in antibody formation or graft rejection.'
raw_completion_output: |-
  primary_disease: sickle cell disease (SCD)

  medical_actions: automated exchange blood transfusions (EBT); kidney transplantation; renal transplantation

  symptoms: Sickle Cell Nephropathy (SCN); End Stage Renal Disease (ESRD); complications of SCD; alloimmunisation; de novo donor specific antibodies (DSAs); graft rejection

  chemicals: 

  action_annotation_relationships: automated exchange blood transfusions (EBT) TREATS complications of SCD IN sickle cell disease; kidney transplantation TREATS End Stage Renal Disease (ESRD) IN sickle cell disease; renal transplantation TREATS End Stage Renal Disease (ESRD) IN sickle cell disease; automated exchange blood transfusions (EBT) PREVENTS alloimmunisation IN sickle cell disease; automated exchange blood transfusions (EBT) PREVENTS de novo donor specific antibodies (DSAs) IN sickle cell disease; automated exchange blood transfusions (EBT) PREVENTS graft rejection IN sickle cell disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  automated exchange blood transfusions (EBT) PREVENTS graft rejection IN sickle cell disease

  ===

extracted_object:
  primary_disease: MONDO:0007374
  medical_actions:
    - automated exchange blood transfusions (EBT)
    - kidney transplantation
    - renal transplantation
  symptoms:
    - HP:0005541
    - HP:0003774
    - complications of SCD
    - alloimmunisation
    - de novo donor specific antibodies (DSAs)
    - graft rejection
  action_annotation_relationships:
    - subject: <automated exchange blood transfusions>
      predicate: <TREATS>
      object: <complications of SCD>
      qualifier: <sickle cell disease>
      subject_qualifier: <>
      object_qualifier: <>
      subject_extension: <automated exchange blood transfusions (EBT)>
      object_extension: <>
    - subject: kidney transplantation
      predicate: TREATS
      object: HP:0003774
      qualifier: MONDO:0011382
    - subject: renal transplantation
      predicate: TREATS
      object: HP:0003774
      qualifier: MONDO:0011382
    - subject: automated exchange blood transfusions (EBT)
      predicate: PREVENTS
      object: alloimmunisation
      qualifier: MONDO:0011382
    - subject: automated exchange blood transfusions (EBT)
      predicate: PREVENTS
      object: de novo donor specific antibodies (DSAs)
      qualifier: MONDO:0011382
    - subject: automated exchange blood transfusions (EBT)
      predicate: PREVENTS
      object: graft rejection
      qualifier: MONDO:0011382
named_entities:
  - id: MONDO:0011382
    label: Sickle Cell Disease
  - id: MAXO:0000457
    label: Pain Management
  - id: HP:0012531
    label: Pain
  - id: HP:0000739
    label: anxiety
  - id: MONDO:0005812
    label: Influenza
  - id: MAXO:0001017
    label: vaccination
  - id: MAXO:0000756
    label: transfusion
  - id: MONDO:0018881
    label: Myelodysplasia
  - id: MONDO:0000984
    label: Thalassemia
  - id: MONDO:0018373
    label: avascular necrosis (AVN)
  - id: MAXO:0009047
    label: total hip replacement (THR)
  - id: HP:0010885
    label: avascular necrosis
  - id: MONDO:0007374
    label: Sickle Cell Disease (SCD)
  - id: CHEBI:131923
    label: Salubrinal
  - id: MAXO:0000068
    label: Transplantation
  - id: CHEBI:44423
    label: hydroxyurea
  - id: MONDO:0003664
    label: Haemolytic Anaemias
  - id: HP:0032654
    label: Endothelial dysfunction
  - id: HP:0025464
    label: Oxidative stress
  - id: MAXO:0001298
    label: therapies
  - id: MAXO:0000110
    label: Vitamin D supplementation
  - id: HP:0100512
    label: Vitamin D deficiency
  - id: CHEBI:27300
    label: Vitamin D
  - id: CHEBI:28940
    label: Cholecalciferol
  - id: CHEBI:29016
    label: Arginine
  - id: CHEBI:18211
    label: Citrulline
  - id: CHEBI:3638
    label: Chloroquine
  - id: CHEBI:50733
    label: Nutritional supplements
  - id: HP:0012532
    label: Chronic pain
  - id: HP:0000716
    label: Depression
  - id: HP:0012432
    label: Chronic fatigue
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplant (HSCT)
  - id: MAXO:0001001
    label: Gene therapy
  - id: HP:0007760
    label: Sickle Cell Disease (SCD)
  - id: MAXO:0035088
    label: magnetic resonance imaging (MRI)/magnetic resonance angiography (MRA)
  - id: HP:0002140
    label: ischemic stroke
  - id: HP:0001139
    label: abnormal transcranial Doppler ultrasound (TCD) results
  - id: MONDO:0006079
    label: Acute Chest Syndrome (ACS)
  - id: HP:0001945
    label: Fever
  - id: HP:0002878
    label: Acute respiratory failure
  - id: CHEBI:82594
    label: Ferritin
  - id: HP:0002204
    label: pulmonary embolism
  - id: CHEBI:50249
    label: anticoagulants
  - id: CHEBI:9570
    label: thiotepa
  - id: CHEBI:82557
    label: treosulfan
  - id: CHEBI:28901
    label: busulfan
  - id: CHEBI:4027
    label: cyclophosphamide
  - id: MAXO:0000750
    label: conditioning regimens
  - id: MAXO:0000618
    label: fluid replacement therapy
  - id: HP:0001919
    label: acute kidney injury
  - id: CHEBI:63895
    label: Interleukin (IL)-6
  - id: CHEBI:197439
    label: TNFalpha
  - id: MONDO:0005502
    label: Dengue fever
  - id: HP:0003326
    label: myalgia
  - id: HP:0002027
    label: abdominal pain
  - id: HP:0002315
    label: headache
  - id: CHEBI:18050
    label: L-glutamine
  - id: MONDO:0018948
    label: Moyamoya disorder (MMD)
  - id: HP:0001250
    label: seizures
  - id: HP:0002360
    label: Sleep disturbances
  - id: HP:0012378
    label: Fatigue
  - id: CHEBI:28876
    label: melphalan
  - id: CHEBI:61049
    label: tacrolimus
  - id: CHEBI:44185
    label: methotrexate
  - id: MAXO:0000004
    label: Surgical intervention
  - id: CHEBI:16335
    label: Adenosine
  - id: CHEBI:177467
    label: Opiorphin
  - id: CHEBI:17347
    label: Testosterone
  - id: MAXO:0000149
    label: hematopoietic cell transplantation (HCT)
  - id: HP:0001297
    label: Stroke
  - id: MONDO:0005151
    label: Endocrinopathy
  - id: HP:0004322
    label: short stature
  - id: HP:0000819
    label: diabetes mellitus
  - id: HP:0000135
    label: hypogonadism
  - id: HP:0000938
    label: osteopenia
  - id: HP:0000939
    label: osteoporosis
  - id: HP:0000821
    label: hypothyroidism
  - id: HP:0008163
    label: hypocortisolism
  - id: HP:0000829
    label: hypoparathyroidism
  - id: HP:0000818
    label: Endocrinopathy
  - id: MAXO:0001175
    label: Liver transplantation
  - id: HP:0002092
    label: Pulmonary hypertension
  - id: MONDO:0013730
    label: Acute Graft-versus-Host Disease (GVHD)
  - id: HP:0001903
    label: anemia
  - id: MONDO:0013517
    label: beta-thalassemia
  - id: HP:0000083
    label: Kidney failure
  - id: HP:0002617
    label: Vasculopathy
  - id: CHEBI:17303
    label: Morphine
  - id: MONDO:0100096
    label: COVID-19
  - id: HP:0031417
    label: rhinorrhea
  - id: HP:0012735
    label: cough
  - id: HP:0025095
    label: sneezing
  - id: HP:0002014
    label: diarrhea
  - id: CHEBI:5588
    label: Hemoglobin A (HbA)
  - id: MAXO:0000602
    label: hemodialysis
  - id: HP:0011675
    label: Arrhythmias
  - id: HP:0012418
    label: Hypoxia
  - id: HP:0001907
    label: thromboembolism
  - id: CHEBI:114786
    label: Sodium metabisulphite
  - id: CHEBI:17790
    label: Methanol
  - id: MAXO:0000127
    label: Genetic testing
  - id: CHEBI:59229
    label: GnRH antagonist
  - id: CHEBI:63533
    label: GnRH agonist
  - id: MAXO:0001490
    label: platelet transfusions
  - id: CHEBI:9168
    label: sirolimus
  - id: MAXO:0009003
    label: Preimplantation genetic testing
  - id: MAXO:0001479
    label: allogeneic hematopoietic stem cell transplantation
  - id: HP:0100602
    label: Preeclampsia
  - id: HP:0001622
    label: Preterm birth
  - id: MONDO:0044348
    label: Hemoglobinopathies
  - id: HP:0100806
    label: Sepsis
  - id: CHEBI:41879
    label: Dexamethasone
  - id: MAXO:0010030
    label: Bone marrow transplantation
  - id: HP:0001878
    label: Hemolytic anemia
  - id: HP:0002904
    label: hyperbilirubinemia
  - id: CHEBI:32026
    label: poloxamer 188
  - id: CHEBI:81579
    label: erythropoietin
  - id: MONDO:0004745
    label: Priapism
  - id: CHEBI:44915
    label: Propofol
  - id: CHEBI:28304
    label: Heparin
  - id: CHEBI:9449
    label: Terbutaline
  - id: MAXO:0000503
    label: Mechanical ventilation
  - id: MAXO:0000600
    label: Renal replacement therapy
  - id: HP:0006554
    label: Acute liver failure
  - id: HP:0100626
    label: End-stage liver disease
  - id: MONDO:0004992
    label: cancer
  - id: MONDO:0012268
    label: AIDS
  - id: MONDO:0003847
    label: genetic disorders
  - id: CHEBI:68554
    label: deferiprone
  - id: CHEBI:49005
    label: deferasirox
  - id: CHEBI:4356
    label: deferoxamine
  - id: CHEBI:33281
    label: antibiotics
  - id: MONDO:0011549
    label: Hyperhaemolysis syndrome (HHS)
  - id: CHEBI:29007
    label: Ceftriaxone
  - id: CHEBI:2955
    label: Azithromycin
  - id: CHEBI:2549
    label: Albuterol
  - id: CHEBI:35341
    label: steroid
  - id: HP:0004870
    label: chronic hemolytic anemia
  - id: HP:0100543
    label: cognitive dysfunction
  - id: MONDO:0019402
    label: Thalassemia Major
  - id: MONDO:0020380
    label: sickle cell anemia (SCA)
  - id: HP:0002754
    label: Osteomyelitis
  - id: HP:0001649
    label: Tachycardia
  - id: HP:0025143
    label: Chills
  - id: HP:0000790
    label: Hematuria
  - id: MONDO:0002050
    label: Depression
  - id: CHEBI:6754
    label: Meperidine
  - id: HP:0000789
    label: infertility
  - id: HP:0008209
    label: premature ovarian insufficiency
  - id: MONDO:0005096
    label: Sickle Cell Crisis (SCC)
  - id: HP:0002860
    label: SCC
  - id: CHEBI:30413
    label: Heme
  - id: CHEBI:15854
    label: Quinine
  - id: CHEBI:17245
    label: Carbon monoxide
  - id: CHEBI:17033
    label: Biliverdin
  - id: HP:0030858
    label: addiction
  - id: CHEBI:50825
    label: Gold nanoparticles (Au NPs)
  - id: CHEBI:35255
    label: chloroform
  - id: CHEBI:27750
    label: ethyl acetate
  - id: CHEBI:4775
    label: ellagic acid
  - id: CHEBI:13193
    label: 3,3',4'-tri-O-methyl ellagic acid (A)
  - id: CHEBI:27560
    label: 3,3'-di-O- methyl ellagic acid (B)
  - id: MONDO:0004995
    label: cardiovascular disease
  - id: CHEBI:125354
    label: Plerixafor
  - id: CHEBI:6129
    label: Ketorolac
  - id: CHEBI:32599
    label: Magnesium sulfate
  - id: CHEBI:6128
    label: Ketoprofen
  - id: CHEBI:5855
    label: Ibuprofen
  - id: CHEBI:6807
    label: Methadone
  - id: CHEBI:16480
    label: Nitric oxide
  - id: CHEBI:6888
    label: Methylprednisolone
  - id: MONDO:0016264
    label: Autoimmune hepatitis (AIH)
  - id: CHEBI:8378
    label: prednisolone
  - id: CHEBI:2948
    label: azathioprine
  - id: MAXO:0001128
    label: Folic Acid Supplementation
  - id: CHEBI:27470
    label: Folic Acid
  - id: CHEBI:35143
    label: Hemoglobin
  - id: MONDO:0005136
    label: Malaria
  - id: HP:0006517
    label: Poor academic performance (PAP)
  - id: MONDO:0800385
    label: Iron overload
  - id: CHEBI:63005
    label: sodium nitrate
  - id: CHEBI:29321
    label: sodium nitroprusside
  - id: CHEBI:17632
    label: nitrate
  - id: HP:0002719
    label: Susceptibility to infections
  - id: HP:0005541
    label: Sickle Cell Nephropathy (SCN)
  - id: HP:0003774
    label: End Stage Renal Disease (ESRD)
